ITMCTR2000003740
Recruiting
Phase 1
A prospective, double-blind, randomized controlled clinical study of Shenshuai II granule in delaying the progression of chronic glomerulonephritis (CKD3 stage)
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The patients who combined the diagnostic criteria of Western medicine for primary chronic glomerulonephritis (more than 50% of them had renal puncture case reports);
- •2\. Patients aged 18\-65 years old;
- •3\. Patients with cgn\-ckd3 (GFR 30\-59ml/min) were diagnosed;
- •4\. Patients with spleen kidney qi deficiency, dampness turbidity and blood stasis type were classified according to TCM syndrome differentiation;
- •5\. Effective control of hypertension patients (blood pressure 130\-90 / 80\-60mmmhg), infection, water electrolyte and acid\-base balance disorder;
- •6\. Patients treated with ACEI / ARB for 2 weeks or without ACEI / ARB before enrollment;
- •7\. Patients with 0\.5g/24h \<\= 24h urinary protein \<\= 2\.5g/24h;
- •8\. Patients with informed consent.
- •Those who meet the above criteria can be included in the observation cases, and those who are no in the above items can not be selected as selected cases.
Exclusion Criteria
- •1\. Patients with single kidney or with autosomal dominant polycystic kidney disease, acquired cyst and large renal space occupying disease.
- •2\. Patients diagnosed with arrhythmia, acute renal failure or chronic renal failure with acute exacerbation.
- •3\. Pregnant or preparing for pregnancy and lactation.
- •4\. Those who are known to be allergic to such drugs, psychotic patients and patients who can not cooperate.
- •5\. Patients who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.
- •6\. Patients who have used western medicine glucocorticoid, immunosuppressant and Tripterygium wilfordii preparation within three months.
- •Those who are yes in any of the above items can not be included in the selected cases.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A prospective, double-blind, randomized controlled trial of TCM syndrome differentiation combined with andis classification in the treatment of stage IV diabetic kidney disease of spleen kidney qi deficiency typeITMCTR2000003821onghua Hospital Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
A randomised, prospective, double-blind controlled study evaluating the effectiveness of spinal endoscopy with adhesiolysis for the treatment of chronic low back paiISRCTN16558617Institutional Review Board of Ambulatory Surgery Center (USA)83
Completed
Not Applicable
A prospective randomised, double-blind controlled trial of intravenous aminophylline versus placebo in patients with acute exacerbations of COPDISRCTN17312089Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)80
Completed
Phase 3
The effect of parecoxib on post craniotomy analgesia.ACTRN12605000600640Department of Anaesthesia, St Vincent's Hospital Melbourne82
Active, not recruiting
Phase 1
Comparison of anesthesia with methohexital to anesthesia with a mixture of propofol and ketamin for electroconvulsive therapysevere uni- or bipolar depression (F32.2, F32.2, F33.2, F33.3, F31.4, F31.5)Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2021-003676-13-ATMedical University of Vienna100